windsor university school of medicine n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
WINDSOR UNIVERSITY SCHOOL OF MEDICINE PowerPoint Presentation
Download Presentation
WINDSOR UNIVERSITY SCHOOL OF MEDICINE

Loading in 2 Seconds...

play fullscreen
1 / 37

WINDSOR UNIVERSITY SCHOOL OF MEDICINE - PowerPoint PPT Presentation


  • 83 Views
  • Uploaded on

WINDSOR UNIVERSITY SCHOOL OF MEDICINE . Dr.Vishal Surender.MD. Nervous System Synapses.  OBJECTIVES. describe the sites of synthesis and storage of small molecule transmitters in nerve terminals list the ionic mechanisms in the vesicular membrane that facilitate transmitter storage

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'WINDSOR UNIVERSITY SCHOOL OF MEDICINE' - brigid


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
windsor university school of medicine
WINDSOR UNIVERSITYSCHOOL OF MEDICINE

Dr.Vishal Surender.MD.

Nervous System

Synapses

slide2

 OBJECTIVES

  • describe the sites of synthesis and storage of small molecule transmitters in nerve terminals
  • list the ionic mechanisms in the vesicular membrane that facilitate transmitter storage
  • review the roles of extracellular and intracellular calcium ions in transmitter release.
  • review the steps in the process of exocytosis of neurotransmitter
  • distinguish between the conditions necessary for release of small molecule transmitters and the co-release of these transmitters and neuropeptides
  • describe the mechanisms for recycling of vesicular membrane following exocytosis
  • describe the mechanisms that alter transmitter release owing to the actions of toxins, drugs and other neurotransmitters
  • review the clinical correlations listed at the end of the lecture handout
chemical synapse
Chemical Synapse
  • Functional connection between a neuron and another neuron or effector cell.
  • These are the junctions where the axon or some other portion of one cell (the presynaptic cell) terminates on the dendrites, soma, or axon of another neuron or, in some cases, a muscle or gland cell (the postsynaptic cell).

axosomatic synapses

axodendritic synapses

axoaxonic synapses

synaptic transmission
Synaptic Transmission
  • AP travels down axon to bouton.
  • NT release is rapid because many vesicles form fusion-complexes at “docking site.”
  • *Voltage Gated Ca2+ channels open.
    • Ca2+ enters bouton down concentration gradient.
    • Inward diffusion triggers rapid fusion of synaptic vesicles and release of NTs.
synaptic transmission continued
Synaptic Transmission (continued)
  • NTs are released and diffuse across synaptic cleft.
  • NT (ligand) binds to specific receptor proteins in postsynaptic cell membrane.
  • *Chemically-regulated/Ligand gated ion channels open.
    • EPSP: depolarization.
    • IPSP: hyperpolarization.
  • Neurotransmitter inactivated to end transmission.
slide6

Excitatory and inhibitory synaptic connections mediating the stretch reflex provide an example of typical circuits within the CNS

functional classification of neurotransmitters
Functional Classification of Neurotransmitters
  • Two classifications: excitatory and inhibitory
    • Excitatory neurotransmitters cause depolarizations(e.g., glutamate)
    • Inhibitory neurotransmitters cause hyperpolarizations(e.g., GABA and glycine)
  • Some neurotransmitters have both excitatory and inhibitory effects
    • Determined by the receptor type of the postsynaptic neuron
    • Example: acetylcholine.
      • Excitatory at neuromuscular junctions
      • Inhibitory with cardiac muscle
neurotransmitter receptor mechanisms
Neurotransmitter Receptor Mechanisms
  • Direct: neurotransmitters that open ion channels(cation/anion channels) Ionotropic
    • Promote rapid responses
    • Examples: Ach in ganglion and neuromuscular junction
  • Indirect: neurotransmitters that act through second messengersmetabotropic
    • Promote long-lasting effects
    • Examples: biogenic amines and peptides involved in memory functions.
slide10

Direct/Ionotropic

  • Composed of integral membrane protein
  • Mediate direct neurotransmitter action
  • Action is immediate, brief, simple, and highly localized
  • Ligand binds the receptor, and ions enter the cells
  • Excitatory receptors depolarize membranes
  • Inhibitory receptors hyperpolarize membranes

Figure 11.22a

g protein linked receptors

Indirect/metabotropic: second messengers

G Protein-Linked Receptors
  • Responses are indirect, slow, complex, prolonged, and often diffuse
  • These receptors are transmembrane protein complexes
  • Examples: muscarinicACh receptors, neuropeptides(learning and memory), and those that bind biogenic amines
g protein linked receptors effects
G Protein-Linked Receptors: Effects
  • G protein-linked receptors activate intracellular second messengers including Ca2+, cyclic GMP, diacylglycerol, as well as cyclic AMP
  • Second messengers:
    • Open or close ion channels
    • Activate kinase enzymes
    • Phosphorylate channel proteins
    • Activate genes and induce protein synthesis
acetylcholine ach as nt
Acetylcholine (ACh) as NT
  • ACh is both an excitatory and inhibitory NT, depending on organ involved.
    • Causes the opening of chemical gated ion channels.
  • Nicotinic ACh receptors:
    • Found in autonomic ganglia and skeletal muscle fibers.
  • MuscarinicACh receptors:
    • Found in the plasma membrane of smooth and cardiac muscle cells, and in cells of particular glands.
ligand operated ach channels
Ligand-Operated ACh Channels
  • Most direct mechanism.
  • Ion channel runs through receptor.
  • Permits diffusion of Na+ into and K+ out of postsynaptic cell.
  • Inward flow of Na+ dominates .
    • Produces EPSPs.

Nicotinic Receptor

acetylcholinesterase ache
Acetylcholinesterase (AChE)
  • Enzyme that inactivates ACh.
    • Present on postsynaptic membrane or immediately outside the membrane.
  • Prevents continued stimulation.

- neostigmine

ach in pns and cns
ACh in PNS and CNS
  • Somatic motor neurons synapse with skeletal muscle fibers.
    • Release ACh from boutons.
    • Produces end-plate potential (EPSPs).
  • Depolarization opens VG channels adjacent to end plate.
  • Myasthenia Gravis
slide19

Central cholinergic neurons project to widespread areas of the cortex and cholinergic activity is responsible for a wide range of behaviors.

Disruption of cholinergic function can produce amnesia, and anticholinergic medications, at toxic levels, are known to produce delirium and delusions.

Neurochemical and neuropathological degenerative findings in the central cholinergic system have been consistently reported in Alzheimer's disease.

Cholinergic excess or hyperactivity has been postulated to play a role in depression and aggressive behaviors.

monoamines as nt
Monoamines as NT
  • Monoamine NTs:
    • Serotonin.
    • Epinephrine.
    • Norepinephrine. Catecholamines
    • Dopamine.
  • Released by exocytosis from presynaptic vesicles.
  • Diffuse across the synaptic cleft.
  • Interact with specific receptors in postsynaptic membrane.
inhibition of monoamines as nt
Inhibition of Monoamines as NT
  • Reuptake of monoamines into presynaptic neuron.
  • Enzymatic degradation of monoamines in presynaptic neuron by MAO-monoamine oxidase.
  • Enzymatic degradation of catecholamines in postsynaptic membrane by COMT-catechol-O-methyltransferase.
mechanism of action
Mechanism of Action
  • Monoamine NT do not directly open ion channels.
  • Act through second messenger, such as cAMP.
  • Binding of norepinephrine stimulates dissociation of G-protein alpha subunit.
  • Alpha subunit binds to adenylatecyclase, converting ATP to cAMP.
  • cAMP activates protein kinase, phosphorylating other proteins.
  • Open ion channels.
serotonin as nt
Serotonin as NT
  • NT (derived from L-tryptophan) for neurons with cell bodies in raphe nuclei(brain stem).
  • Regulation of mood, behavior, appetite, and cerebral circulation.
  • SSRIs (serotonin-specific reuptake inhibitors):prozac
    • Inhibit reuptake and destruction of serotonin, prolonging the action of NT.
    • Used as an antidepressant.
      • Reduces appetite, treatment for anxiety, treatment for migraine headaches.
dopamine as nt
Dopamine as NT
  • NT for neurons with cell bodies in midbrain.
  • Axons project into:
    • Nigrostriatal dopamine system:
      • Nuerons in substantianigra send fibers to corpus straitum.
      • Initiation of skeletal muscle movement.
      • Parkinson’s disease: degeneration of neurons in substantianigra.
    • Mesolimbic dopamine system:
      • Neurons originate in midbrain, send axons to limbic system.
      • Involved in behavior.
      • Addictive drugs:-Promote activity in nucleus accumbens(striatum). Cocaine, schizophrenia.
norepinephrine ne as nt
Norepinephrine (NE) as NT
  • NT in both PNS and CNS.
  • PNS:
    • Smooth muscles, cardiac muscle and glands.
      • Increase in blood pressure, constriction of arteries.
  • CNS:
    • General behavioral arousal.
    • amphetamines
amino acids as nt
Amino Acids as NT
  • Glutamic acid and aspartic acid:
    • Major excitatory NTs in CNS.
  • Glutamic acid:
    • NMDA receptor involved in memory storage.
  • Glycine:
    • Inhibitory, produces IPSPs.
    • Opening of Cl- channels in postsynaptic membrane.
      • Hyperpolarization.
    • Helps control skeletal movements.
  • GABA (gamma-aminobutyric acid):
    • Most prevalent NT in brain.
    • Inhibitory, produces IPSPs.
      • Hyperpolarizes postsynaptic membrane.
        • Motor functions in cerebellum. Ex-huntingtons chorea.
slide29

Clinical Correlations

  • Botulinum Toxin
  •  Microinjection of botulinum toxin has been used to treat dystonias (irregular and troublesome clonic contractions of muscle). One effect is the block of ACh release. It has also been used in cosmetic surgery to reduce facial wrinkles.
  • Snake Venom
  •  The venoms of some snakes contain a component (beta-bungarotoxin) that binds irreversibly to actin and possibly other cytoskeletal components in cholinergic nerve endings, and blocks ACh release. Resulting paralysis can prove fatal if the subject is not ventilated.
slide30

Therapeutic Drugs Act within the CNS on ReceptorsAnti-anxiety drugs act on GABAA receptor channels

Benzodiazepines and barbiturates: inhibition in the amygdala involved with the development of fear and anxiety.

The binding pocket for benzodiazepines is located in a subunit cleft between gamma and alpha1 subunits

Agonist binding site for GABA is located between alpha1 and beta2 subunits.

slide31

Therapeutic Drugs Act within the CNS on ReceptorsSeveral drugs are used to treat mood disorders

Clinical depression:

  • Selective serotonin re-uptake inhibitors (SSRIs; e.g.Prozac,in preference to the former use of tricyclic anti-depressants).
  • Noradrenaline re-uptake inhibitors

MAO inhibitors to reduce the degradation of noradrenaline and serotonin.